# Caring Brands, Inc.: financial statements, quarterly

CABR · Nasdaq · CIK 2020737 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cabr.md) · [Financials](/companies/cabr/financials.md) · [Filings](/companies/cabr/filings.md) · [Insiders](/companies/cabr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cabr/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-09-24) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | [0.5](/filings/0001493152-26-013844.md) | [1.5](/filings/0001493152-26-022506.md) | [1.6](/filings/0001493152-26-037602.md) | [0.7](/filings/0001493152-25-023541.md) | [0.4 d](/filings/0001493152-26-013844.md) | not reported | not reported |
| Cost of revenue | $k | not reported | [2.1](/filings/0001493152-26-013844.md) | [0.7](/filings/0001493152-26-022506.md) | [0.7](/filings/0001493152-26-037602.md) | [0.3](/filings/0001493152-25-023541.md) | [0.2 d](/filings/0001493152-26-013844.md) | not reported | not reported |
| Gross profit | $k | not reported | [(1.6)](/filings/0001493152-26-013844.md) | [0.8](/filings/0001493152-26-022506.md) | [0.9](/filings/0001493152-26-037602.md) | [0.4](/filings/0001493152-25-023541.md) | [0.2 d](/filings/0001493152-26-013844.md) | not reported | not reported |
| Research and development | $k | not reported | [0.0 d](/filings/0001493152-26-013844.md) | not reported | not reported | not reported | [0.0 d](/filings/0001493152-26-013844.md) | not reported | not reported |
| Selling, general and administrative | $k | [156](/filings/0001493152-25-023541.md) | [26.5](/filings/0001493152-26-013844.md) | [30.2](/filings/0001493152-26-022506.md) | [21.3](/filings/0001493152-26-037602.md) | [1,000](/filings/0001493152-25-023541.md) | [(2,053) d](/filings/0001493152-26-013844.md) | [88.5](/filings/0001493152-26-022506.md) | [26.2](/filings/0001493152-26-037602.md) |
| Operating income | $k | [(156)](/filings/0001493152-25-023541.md) | [(873)](/filings/0001493152-26-013844.md) | [(539)](/filings/0001493152-26-022506.md) | [(660)](/filings/0001493152-26-037602.md) | [(999)](/filings/0001493152-25-023541.md) | [(3,737) d](/filings/0001493152-26-013844.md) | [(1,721)](/filings/0001493152-26-022506.md) | [(639)](/filings/0001493152-26-037602.md) |
| Interest expense | $k | [0.1](/filings/0001493152-25-023541.md) | [(10.0)](/filings/0001493152-26-013844.md) | [0.4](/filings/0001493152-26-022506.md) | [0.0 d](/filings/0001493152-26-037602.md) | [19.3](/filings/0001493152-25-023541.md) | [(0.6) d](/filings/0001493152-26-013844.md) | [287](/filings/0001493152-26-022506.md) | [0.0](/filings/0001493152-26-037602.md) |
| Income tax | $k | not reported | not reported | [0.0](/filings/0001493152-26-022506.md) | [0.0 d](/filings/0001493152-26-037602.md) | not reported | not reported | [0.0](/filings/0001493152-26-022506.md) | [0.0 d](/filings/0001493152-26-037602.md) |
| Net income | $k | [(156)](/filings/0001493152-25-023541.md) | [(863)](/filings/0001493152-26-013844.md) | [(539)](/filings/0001493152-26-037602.md) | [(661)](/filings/0001493152-26-037602.md) | [(1,019)](/filings/0001493152-25-023541.md) | [(4,060) d](/filings/0001493152-26-013844.md) | [(2,008)](/filings/0001493152-26-037602.md) | [(639)](/filings/0001493152-26-037602.md) |
| Diluted EPS | $ per share | not reported | [(0.07)](/filings/0001493152-26-013844.md) | [(0.04)](/filings/0001493152-26-022506.md) | [(0.05)](/filings/0001493152-26-037602.md) | [(0.08)](/filings/0001493152-25-023541.md) | not reported | [(0.27)](/filings/0001493152-26-022506.md) | [(0.10)](/filings/0001493152-26-037602.md) |
| Basic EPS | $ per share | not reported | [(0.07)](/filings/0001493152-26-013844.md) | [(0.04)](/filings/0001493152-26-022506.md) | [(0.05)](/filings/0001493152-26-037602.md) | [(0.08)](/filings/0001493152-25-023541.md) | not reported | [(0.27)](/filings/0001493152-26-022506.md) | [(0.10)](/filings/0001493152-26-037602.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-09-24) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $k | not reported | not reported | [469](/filings/0001493152-26-013844.md) | not reported | not reported | [16.1](/filings/0001493152-25-023541.md) | [2,189](/filings/0001493152-26-037602.md) | [2,033](/filings/0001493152-26-022506.md) | [1,820](/filings/0001493152-26-037602.md) |
| Current assets | $k | not reported | not reported | [527](/filings/0001493152-26-013844.md) | not reported | not reported | [46.0](/filings/0001493152-25-023541.md) | [2,327](/filings/0001493152-26-037602.md) | [2,172](/filings/0001493152-26-022506.md) | [1,910](/filings/0001493152-26-037602.md) |
| Total assets | $k | not reported | not reported | [3,877](/filings/0001493152-26-013844.md) | not reported | not reported | [3,171](/filings/0001493152-25-023541.md) | [2,327](/filings/0001493152-26-037602.md) | [2,172](/filings/0001493152-26-022506.md) | [1,910](/filings/0001493152-26-037602.md) |
| Current liabilities | $k | not reported | not reported | [186](/filings/0001493152-26-013844.md) | not reported | not reported | [570](/filings/0001493152-25-023541.md) | [177](/filings/0001493152-26-037602.md) | [384](/filings/0001493152-26-022506.md) | [385](/filings/0001493152-26-037602.md) |
| Total liabilities | $k | not reported | not reported | [186](/filings/0001493152-26-013844.md) | not reported | not reported | [572](/filings/0001493152-25-023541.md) | [235](/filings/0001493152-26-037602.md) | [384](/filings/0001493152-26-022506.md) | [385](/filings/0001493152-26-037602.md) |
| Long-term debt | $k | not reported | not reported | not reported | not reported | not reported | [1.9](/filings/0001493152-25-023541.md) | [58.7](/filings/0001493152-26-037602.md) | not reported | not reported |
| Current portion of debt | $k | not reported | not reported | not reported | not reported | not reported | [129](/filings/0001493152-25-023541.md) | not reported | not reported | not reported |
| Shareholders' equity | $k | [(266)](/filings/0001493152-26-013844.md) | [(920)](/filings/0001493152-26-013844.md) | [3,691](/filings/0001493152-26-037602.md) | [3,378](/filings/0001493152-26-037602.md) | [3,105](/filings/0001493152-26-037602.md) | [2,599](/filings/0001493152-25-023541.md) | [2,091](/filings/0001493152-26-037602.md) | [(2,002)](/filings/0001493152-26-037602.md) | [(2,708)](/filings/0001493152-26-037602.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(272)](/filings/0001493152-26-013844.md) | [(242)](/filings/0001493152-26-022506.md) | [(209) d](/filings/0001493152-26-037602.md) | [(181) d](/filings/0001493152-25-023541.md) | [(1,060) d](/filings/0001493152-26-013844.md) | [(551)](/filings/0001493152-26-022506.md) | [(463) d](/filings/0001493152-26-037602.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | [3,075](/filings/0001493152-26-022506.md) | [0.0 d](/filings/0001493152-26-037602.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [13.1](/filings/0001493152-26-013844.md) | [13.2](/filings/0001493152-26-022506.md) | [13.3](/filings/0001493152-26-037602.md) | [13.4](/filings/0001493152-25-023541.md) | [14.4](/filings/0001493152-26-022506.md) | [9.0](/filings/0001493152-26-037602.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,368,226 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001493152-26-037602.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.